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Abstract
Background: Surgical excision of the primary tumor with safe margins remains the mainstay of treatment for oral
cavity squamous cell carcinoma (OSCC). The standard of care for assessment of intraoperative margins is frozen
section histopathology. Unfortunately the facility is not available at most centers in limited resource countries.
Toluidine blue, a metachromatic dye, has been well described in clinical identification of malignant and
premalignant lesion in the oral cavity. Considering this we decided to explore intraoperative use of toluidine blue
staining, in comparison with frozen sections, for the assessment of tumor-free margins.
Methods: After obtaining clearance from the in-house ethical review committee, a prospective study was
conducted at Aga Khan University Hospital, Karachi, from August 15, 2009 to March 14, 2010. A sample of 56
consenting patients with biopsy-proven OSCC were included in the study, giving us 280 tumor margins. Margins
were analyzed using toluidine blue staining and frozen section histopathology. A receiver operator curve (ROC)
was then applied to compare assessment of margin status by toluidine blue and frozen section.
Results: Of the 280 examined margins 11 stained positive with toluidine blue, three were positive on frozen
section biopsy, and three were positive on final histopathology. Toluidine blue staining had sensitivity and
specificity of 100% and 97%, respectively. The diagnostic accuracy of toluidine blue was found to be 97.1% with a
positive predictive value (PPV) of 27.2% and a negative predictive value (NPV) of 100%.
Conclusions: Toluidine blue can be used as an effective screening modality for the assessment of intraoperative
margins in resource limited environments and reducing the number of frozen section biopsies performed. Further
by providing real-time clinical information within minutes it can reduce indirect costs such as operating room time.
It may also be used as an ad hoc for frozen section biopsies where frozen section facilities are available.

Background
When assessing the incidence and prevalence of cancers
the International Agency for Research on Cancer, an
arm of the World Health Organization (WHO), ranked
head and neck cancers as the sixth most common
malignancies in males [1]. Contributing to the same
database, Bhurgri et al.; while reviewing their data from
Karachi, Pakistan found a higher burden of disease [2].
In the local data, head and neck neoplasms accounted
for the highest number of malignant neoplasm in males
(age standardized rate (ASR) of 22.5 per 100,000) and
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the second highest number in females (ASR of 20.4 per
100,000) [2]. Given the prevalent cultural practices of
chewing betel nuts and tobacco, it came as no surprise
that the most frequent site for these neoplasms was the
oral cavity and squamous cell carcinoma the most predominant subtype [2,3]. The alarmingly high incidence
of oral cavity and squamous cell carcinoma (OCSCC) is
indeed a major health issue for a third world country,
with a staggering economy and a fee for service health
structure. The situation is further marred by the absence
of screening protocols.
The mainstay of treatment of OSCC involves surgical
excision of the primary tumor with safe margins [4].
This may be augmented by radiation therapy with or
without chemotherapy. However intraoperative assessment of tumor margins remains a major health issue.
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Methods of identifying tumor-involved margins include
visualization and simultaneous palpation of the resected
margins but with a chance that microscopic disease will
be left behind. Frozen section biopsies are used as the
standard of care in this regard in developed countries.
Given the status of healthcare systems in limited
resource settings like ours, it is not available in a majority of centers. On an average, the cost of five frozen
margins in a patient is approximately US$75. Adding to
this is the fact that over half the population lives on less
than US$2 a day, making the service where available out
of reach for a majority of patients.
Toluidine blue is an easily available, economical, metachromatic dye known to bind DNA of dividing cells. It
has previously been described to stain malignant and
premalignant cells but not normal mucosa [5-7]. Multiple studies have reported the use of toluidine blue as a
screening tool for oral malignant and pre-malignant
lesions [8-12], with sensitivity and specificity between
the ranges of 93.5% and 97.8% and 73.3% and 92.9%,
respectively [13]. Given this background we decided to
test toluidine blue for assessment of intraoperative
tumor margins after the excision of primary oral cavity
tumor.

Method
After ethical clearance from the institutional ethics
review committee, a prospective study at The Aga Khan
University Hospital, Karachi, Pakistan was conducted
from August 15, 2009 to March 14, 2010 on 56 consenting patients with biopsy-proven OCSCC, undergoing
primary excision. Patients with prior history of head and
neck malignancy, tumors of the oro-pharynx or having
previously undergone treatment (surgery and/or radio-/
chemotherapy) for the current oral squamous cell carcinoma were excluded from the study as increased inflammation and scar tissue could possibly lead to errors
while interpreting the staining results. The patients were
recruited regardless of the age, gender, ethnicity, and
tumor stage.
All procedures were performed by experienced head
and neck surgeons with assistance from senior residents.
The operative protocol was essentially the same with
minor differences due to the individual tumor status
and attending surgeon’s preference. After excision of the
primary tumor a trained senior resident stained the
tumor margins as per the defined protocol. Once the
senior was done painting the margins and had recorded
his findings, the primary surgeon took frozen biopsies
from clinically suspicious areas regardless of staining
pattern as per institutional protocol. In addition if any
margin stained positive with toluidine blue the primary
surgeon was requested to take a frozen section biopsy
from the area. Each frozen section biopsy was sent in a
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different container with labeling of the site from which
it was obtained. A log was maintained of the staining
results. The senior resident and the histopathologist
were blinded to each other’s findings (histopathologist
for the staining pattern, senior resident for frozen
results). However the staining may have persisted after
processing and may have had an influence on the histopathologist’s decision. The results of the frozen section
biopsy were directly conveyed to the attending physician
via the operating room (OR) phone. The senior resident
performing the staining was not present in the OR at
the time these results were conveyed. The results where
then compared and contrasted with the findings of frozen section biopsy and final histopathology by another
author. No intraoperative action, other than frozen section biopsy, was taken on the basis of positive staining
margins on toluidine blue, due to the inherent surgical
protocol of our institution. However if a margin was
declared positive on frozen section histopathology it was
further excised and sent for frozen section again till the
time it came out negative.
Staining procedure

One per cent toluidine blue solution, as described by
Meshberg et al. was kept in the OR. Once the primary
tumor was excised a designated senior resident irrigated
the tumor margins with normal saline, followed by 1%
acetic acid. The margins were then gently dried with
gauze and painted with the 1% toluidine blue solution
with a cotton swab. The stain was left in place for 30 s
after which the tissue was once again irrigated with normal saline followed by 1% acetic acid. The staining patterns were observed and noted by the senior resident
independently. Margins which stained dark blue were
considered to be positive, whereas those which stained
light blue or did not take the stain at all were considered negative. In order to establish staining patterns we
used simultaneous frozen sections in two pilot patients
and revealed the results to the interpreter during the
surgery, the results of which were not included in the
study.
Statistical analysis

The data were entered and analyzed using Statistical
Package for Social Sciences (SPSS) version 17 (IBM Corporation). Means with standard deviations were calculated for all continuous variables while proportions and
percentages were calculated for categorical variables. A
2 × 2 table was constructed from the acquired data, and
the measures of yield (sensitivity and specificity) and
reliability (negative predictive value and positive predictive value) were calculated using Microsoft Excel 2010
(Microsoft Corporation). Separate 2 × 2 tables were
constructed using SPSS for each category of T stage and
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tumor site to calculate above measures. A receiver
operator curve (ROC) was then applied to compare the
margin status between toluidine blue and frozen section.

Results
Out of 56 patients the majority (75%) were men. About
280 margins were sampled from this pool of patients.
Mean age of the patients was 50.07 ± 15.73 years. Buccal mucosa tumors accounted for 41% (n = 23) of the
lesions. This was followed by the tongue 23.2% (n = 13),
lower alveolus 12.5% (n = 7), retro-molar trigone 8.95%
(n = 5) and the floor of the mouth 5.3% (n = 3). When
considering the extent of the lesion 19.6% (n = 11)
patients were staged as T1, while 33.9% (n = 19) were
staged as T2, 19.6% (n = 11) as T3 and 26.7% (n = 15)
as T4.
Of the 280 examined margins 11 stained positive with
toluidine blue. However of these 11 margins three were
true-positives, that is positive on frozen section biopsy
and/or final histopathology (Table 1). There were no
false-negatives, that is toluidine blue was able to identify
all true positive margins. While all the positive cases
were picked up on staining with toluidine blue indicating a sensitivity of 100%, 8/280 (2.8%) false-positives
were also identified indicating a specificity of 97%. The
diagnostic accuracy of toluidine was found to be 97.1%
with a positive predictive value (PPV) of 27.2% and a
negative predictive value (NPV) of 100%.
On stratified analysis, the sensitivity and NPV
remained unchanged across all the strata of T stage and
tumor sites. In contrast, specificity and PPV were found
to decrease with larger stage III and IV tumors; however
they did not fall below acceptable levels (Table 2). In
our study the results of the frozen section biopsies were
in concordance with the findings on final histo-pathological examination. (Table 3) Hence comparison of toluidine blue staining to frozen section biopsies and
histopathology revealed the same results. We did not
come across any dysplasia on final histopathology.
As per ROC analysis, for a randomly selected margin
positive case, there is a 98% chance that toluidine-predicted probability of margin positivity will be higher
than a randomly selected margin negative case. This can
Table 1 A 2 × 2 table showing the comparison of results
of toluidine blue with frozen section
Frozen section/Final
histopathology
Margin Status +ve
Toluidine Blue +ve
Total

Total

-ve

3

8

11

-ve

0

269

269

3

277

280

When applying the ROC analysis we found that the low positive predictive
value was significant (P = 0.004).

Table 2 Showing the yield (sensitivity and specificity)
and reliability (PPV and NPV) of toluidine blue as
compared to frozen section biopsy and histopathological
examination
Sensitivity

Specificity

PPV

NPV

100%

97.1%

27.2%

100%

T-I

-

98.1%

-

100%

T-II

100%

100%

100%

100%

T-III

100%

98.1%

50%

100%

100%

91.8%

14%

100%
100%

Overall
T-Stage

T-IV
Tumor
Buccal

Site
mucosa

100%

97.3%

25%

Tongue

100%

98.4%

50%

100%

RetromolarTrigone

-

96%

-

100%

Lower

alveolus

100%

94.1%

33.3%

100%

Upper

alveolus

-

96%

-

100%

-

100%

-

100%

Floor of mouth

PPV positive predictive value, NPV negative predictive value

also be explained that the probability of a toluidine positive case to become positive on histopathology by
chance alone is 0.4% (AUC: 0.986, 95% CI: 0.968-1, P
value: 0.004) (Figure 1).

Discussion
Toluidine blue, also known by its chemical name tolunium chloride, is a basic metachromatic dye that is
known for its property of differentially staining malignant neoplasm but not normal epithelium [14]. It is postulated that the increased amount of DNA and RNA in
neoplastic cells and the wider intercellular canals compared to normal epithelial cells are responsible for staining malignant cells [7]. Its clinical application in staining
neoplastic cells was first described by Richart in 1963,
who used the dye to stain cervical carcinoma in situ
[15]. Since then it has emerged as a vital stain for detection of cervical dysplasia and carcinoma during colposcopy. More recently toluidine blue has also been
described as an adjunct to clinical examination for the
detection of malignant and premalignant oral cavity
lesions [7,16]. Epstein et al., while screening for recurrence in patients who had previously been treated for
upper aero-digestive tract malignancies, found that the
use of toluidine blue in an unaided clinical exam
increased the sensitivity of detecting a malignant neoplasm from 26.6% to 96.7% [8]. In all fairness its ability
to detect malignant oral cavity lesions has been well
documented in clinical settings [17,18]. However its use
in intraoperative identification of tumor margins has not
been well described. Considering its ability to effectively
stain malignant cells in contrast to normal epithelium
we postulated that it could offer a low cost facility in
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Table 3 Illustrating the 11 cases of positive staining margins with toluidine blue compared to the frozen section
biopsy and final histopathology results
No.

Site of primary tumor

T staging

Frozen section biopsy results

Final histopathology results

1

Tongue

III

+ve

+ve

2

Retromolar trigone

III

-ve

-ve

3
4

Buccal mucosa
Buccal mucosa

IV
IV

+ve
-ve

+ve
-ve

5

Buccal mucosa

IV

-ve

-ve

6

Buccal mucosa

IV

-ve

-ve

7

Tongue

IV

-ve

-ve

8

Lower alveolus

IV

+ve

+ve

9

Lower alveolus

IV

-ve

-ve

10

Lower alveolus

IV

-ve

-ve

11

Upper alveolus

IV

-ve

-ve

developing countries, where frozen section is not easily
available.
In order to arrive at our conclusion we compared the
findings of toluidine blue to frozen section biopsies
(standard of care) and final histopathology (gold standard). We found the findings of frozen section biopsies
in our sample to be 100% concurrent with the final
histopathology. So comparison of toluidine blue with
either was equivalent. In our study sample staining
with toluidine blue had an intraoperative sensitivity of

Figure 1 Receiver operator curve showing the area under the
curve for toludine blue at different levels of specificity 98.6%
(AUC: 0.986, 95% CI: 0.968-1, p-value: 0.004. The green and blue
lines represent thediagonal and toluidine blue respectively.

100% and a specificity of 97% with a NPV of 100% and
a PPV of 27.2%. These figures are in agreement with
previous studies done in clinical settings; with slightly
higher sensitivity. This could probably be explained by
the fact that all the studies quoted above present staining in a clinical scenario whereas our study toluidine
blue was used intraoperatively, which allowed a uniform staining protocol to be followed with adequate
time for observation
In our study, 11 margins stained positive with toluidine blue, of which three were positive on frozen section
biopsy and final histopathology. This low PPV was significant. ROC analysis revealed a P value of 0.004. Falsepositive results have also been shown to be associated
with inflammation secondary to increased mucosal
trauma during excision [19], indicating that careful
handling of the tissue during excision may increase the
PPV. However we would highlight the fact that the test
had an NPV of 100%, indicating that it did not miss a
single positive margin. While reviewing literature we
found only one study accessing the use of toluidine blue
intraoperatively. In this study, Portugal et al. pointed
out that staining with toluidine blue identified all positive tumor margins with few false-positives and no falsenegatives [20]. Further the study added that staining
identified three incidences of second primary lesion that
was not previously identified [20]. Missmann et al. also
reported that toluidine blue staining could not only be
used to effectively localize tumor borders but also detect
satellite lesions within 1 cm of the primary lesions [21].
We cannot comment on the identification of second primaries, satellite or dysplastic lesions as none were
detected in our study.
In resource-limited environments where facilities for
frozen section biopsies are not readily available surgeons
often rely on either their clinical judgment or on the
final postoperative histopathology for assessing microscopic extension of the disease. This leads to a major

Junaid et al. World Journal of Surgical Oncology 2012, 10:57
http://www.wjso.com/content/10/1/57

disadvantage for patients and may account for high
recurrence rates of OCSCC in developing countries.
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8.

9.

Conclusion
Coupled with the huge burden of OCSCC in Pakistan
[2,22], the risk of recurrence with inadequate excision of
the lesion poses a great health and economic challenge
to the staggering health system. Given our findings and
those reported in literature we feel that toluidine blue
can be an effective screening modality for intraoperative
margins in resource-limited environments. The number
of frozen section biopsies can be limited to the number
of positive staining margins, where the facilities of frozen section biopsies are available. The consideration of
replacing frozen section biopsies by toluidine blue in
resource-limited environments is premature; only with a
trial on a larger cohort can such implications be made.
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